Charles Schwab’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.1M Buy
1,173,560
+1,243
+0.1% +$29.7K ﹤0.01% 1583
2025
Q4
$31.3M Sell
1,172,317
-31,771
-3% -$759K ﹤0.01% 1462
2025
Q3
$25.7M Buy
1,204,088
+14,227
+1% +$336K ﹤0.01% 1592
2025
Q2
$25.7M Sell
1,189,861
-10,978
-0.9% -$204K ﹤0.01% 1532
2025
Q1
$19.9M Sell
1,200,839
-50,493
-4% -$917K ﹤0.01% 1643
2024
Q4
$23M Sell
1,251,332
-19,803
-2% -$320K ﹤0.01% 1626
2024
Q3
$19.6M Sell
1,271,135
-4,144
-0.3% -$69.1K ﹤0.01% 1703
2024
Q2
$20.7M Buy
1,275,279
+86,236
+7% +$1.39M ﹤0.01% 1665
2024
Q1
$22M Buy
1,189,043
+61,136
+5% +$1.51M 0.01% 1556
2023
Q4
$35.3M Buy
1,127,907
+54,814
+5% +$1.31M 0.01% 1226
2023
Q3
$22.4M Buy
1,073,093
+91,641
+9% +$2.49M 0.01% 1439
2023
Q2
$23.5M Buy
981,452
+12,158
+1% +$270K 0.01% 1383
2023
Q1
$18.2M Sell
969,294
-2,460
-0.3% -$46.9K 0.01% 1544
2022
Q4
$15.5M Buy
971,754
+19,080
+2% +$298K 0.01% 1603
2022
Q3
$15.6M Buy
952,674
+35,513
+4% +$575K 0.01% 1557
2022
Q2
$12.9M Sell
917,161
-19,613
-2% -$366K ﹤0.01% 1698
2022
Q1
$22.7M Buy
936,774
+53,773
+6% +$1.3M 0.01% 1441
2021
Q4
$20.6M Buy
883,001
+61,899
+8% +$1.24M 0.01% 1550
2021
Q3
$13.6M Sell
821,102
-288,267
-26% -$5.56M ﹤0.01% 1834
2021
Q2
$27.1M Buy
1,109,369
+262,806
+31% +$5.93M 0.01% 1339
2021
Q1
$21.8M Sell
846,563
-10,807
-1% -$476K 0.01% 1462
2020
Q4
$45.8M Sell
857,370
-38,177
-4% -$1.9M 0.02% 817
2020
Q3
$36.9M Buy
895,547
+160,482
+22% +$6.93M 0.02% 824
2020
Q2
$35.6M Sell
735,065
-107,893
-13% -$5.18M 0.02% 784
2020
Q1
$35.6M Buy
842,958
+112,135
+15% +$4.62M 0.02% 660
2019
Q4
$31.3M Buy
730,823
+95,151
+15% +$4.14M 0.02% 920
2019
Q3
$22.9M Sell
635,672
-95,320
-13% -$2.89M 0.01% 1047
2019
Q2
$19.5M Buy
730,992
+29,031
+4% +$742K 0.01% 1153
2019
Q1
$18.8M Buy
701,961
+111,155
+19% +$2.6M 0.01% 1152
2018
Q4
$9.55M Buy
590,806
+17,828
+3% +$346K 0.01% 1487
2018
Q3
$11.9M Sell
572,978
-131,184
-19% -$2.06M 0.01% 1520
2018
Q2
$10.8M Buy
704,162
+257,871
+58% +$4.6M 0.01% 1554
2018
Q1
$10M Sell
446,291
-4,418
-1% -$122K 0.01% 1494
2017
Q4
$13.6M Buy
450,709
+28,104
+7% +$899K 0.01% 1274
2017
Q3
$15.9M Buy
422,605
+33,478
+9% +$1.09M 0.01% 1093
2017
Q2
$10.9M Buy
389,127
+24,165
+7% +$720K 0.01% 1295
2017
Q1
$12.5M Buy
364,962
+57,279
+19% +$2.02M 0.01% 1148
2016
Q4
$8.87M Sell
307,683
-76
-0% -$2.01K 0.01% 1346
2016
Q3
$9.79M Buy
307,759
+109,236
+55% +$3.7M 0.01% 1178
2016
Q2
$6.45M Sell
198,523
-112,880
-36% -$3.78M 0.01% 1393
2016
Q1
$8.71M Buy
311,403
+20,899
+7% +$456K 0.01% 1128
2015
Q4
$10.4M Buy
290,504
+14,827
+5% +$522K 0.01% 1000
2015
Q3
$9.12M Buy
275,677
+10,415
+4% +$433K 0.01% 1056
2015
Q2
$11.1M Buy
265,262
+8,114
+3% +$314K 0.02% 953
2015
Q1
$8.38M Buy
257,148
+35,754
+16% +$1.23M 0.01% 1126
2014
Q4
$7.03M Buy
221,394
+8,169
+4% +$232K 0.01% 1166
2014
Q3
$5.28M Sell
213,225
-3,437
-2% -$80.4K 0.01% 1324
2014
Q2
$4.89M Buy
216,662
+10,424
+5% +$218K 0.01% 1413
2014
Q1
$5.02M Buy
206,238
+20,314
+11% +$514K 0.01% 1328
2013
Q4
$4.65M Buy
185,924
+7,790
+4% +$184K 0.01% 1318
2013
Q3
$5M Buy
178,134
+20,428
+13% +$427K 0.01% 1184
2013
Q2
$2.86M Buy
+157,706
New +$2.17M 0.01% 1498

Other funds holding ACAD